Single-dose flu drug can reduce spread within households, study finds (IMAGE)
Caption
"This trial established that baloxavir, if taken within a day or so after exposure, is highly effective for preventing influenza illness in households, a high-risk setting for virus transmission," said researcher Frederick G. Hayden, MD, of the University of Virginia School of Medicine. "The findings indicate that baloxavir prophylaxis should prove effective for prevention in other circumstances, such as outbreaks in nursing homes and healthcare facilities, although formal studies will need to be undertaken."
Credit
Dan Addison | UVA Communications
Usage Restrictions
May be used to accompany news coverage of the baloxavir study. All other uses require express written consent from UVA Health.
License
Licensed content